Molecular recognition of glyconanoparticles by RCA and E. coli K88 - Designing transports for targeted therapy

Amed Gallegos-Tabanico, Jose A. Sarabia-Sainz*, H. Manuel Sarabia-Sainz, Roberto Carrillo Torres, Ana M. Guzman-Partida, Gabriela Ramos Clamont Monfort, Erika Silva-Campa, Alexel J. Burgara-Estrella, Aracely Angulo-Molina, Mónica Acosta-Elias, Martín Pedroza-Montero, Luz Vazquez-Moreno

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


The targeted drug delivery has been studied as one of the main methods in medicine to ensure successful treatments of diseases. Pharmaceutical sciences are using micro or nano carriers to obtain a controlled delivery of drugs, able to selectively interact with pathogens, cells or tissues. In this work, we modified bovine serum albumin (BSA) with lactose, obtaining a neoglycan (BSA-Lac). Subsequently, we synthesized glyconanoparticles (NPBSA-Lac) with the premise that it would be recognized by microbial galactose specific lectins. NPBSA- Lac were tested for bio-recognition with adhesins of E. coli K88 and Ricinus communis agglutinin I (RCA). Glycation of BSA with lactose was analyzed by electrophoresis, infrared spectroscopy and fluorescence. Approximately 41 lactoses per BSA molecule were estimated. Nanoparticles were obtained using water in oil emulsion method and spheroid morphology with a range size of 300-500 nm was observed. Specific recognition of NPBSA- Lac by RCA and E. coli K88 was displayed by aggregation of nanoparticles analyzed by dynamic light scattering and atomic force microscopy. The results indicate that the lactosylated nanovectors could be targeted at the E. coli K88 adhesin and potentially could be used as a transporter for an antibacterial drug.

Original languageEnglish
Pages (from-to)671-677
Number of pages7
JournalActa Biochimica Polonica
Issue number4
StatePublished - 2017


  • Bio-recognition
  • Bovine serum albumin
  • Drug delivery
  • Nanoparticles
  • Neoglycan


Dive into the research topics of 'Molecular recognition of glyconanoparticles by RCA and E. coli K88 - Designing transports for targeted therapy'. Together they form a unique fingerprint.

Cite this